RNA-Seq – News and Features

News
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.

News
Hot Processor Speeds Up UK Genome Analysis
The Genome Analysis Centre (TGAC) is the first Institute in the UK to deploy a new bioinformatics processor called DRAGEN™, which dramatically reduces genomic pipeline run times from hours to minutes.

News
Scientists Develop Genetic Blueprint of Inner Ear Cell Development
Two studies in mice use new technique to provide insight into cell development critical for hearing, balance.

News
Researchers learn how to grow old brain cells
For the first time, scientists can use skin samples from older patients to create brain cells without rolling back the youthfulness clock in the cells first. The new technique, which yields cells resembling those found in older people's brains, will be a boon to scientists studying age-related diseases like Alzheimer's and Parkinson's.

News
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.

News
Selvita Launches New Company
Bioinformatics and personalized medicine focused Ardigen.

News
Agilent Announces Opening of Life Science Research Center
Facility designed to advance multi-omics research.

News
Stem cell-derived ‘organoids’ help predict neural toxicity
A new system developed by scientists at the Morgridge Institute for Research and the University of Wisconsin (UW)-Madison may provide a faster, cheaper and more biologically relevant way to screen drugs and chemicals that could harm the developing brain.

News
Stem Cell-Derived 'Organoids' Help Predict Neural Toxicity
A new system developed by scientists may provide a faster, cheaper and more biologically relevant way to screen drugs and chemicals that could harm the developing brain.

News
Genfit Announces Positive Results From Proprietary Nash Biomarker Program
The company has designed a diagnostic tool – as an alternative to invasive liver biopsy – to identify NASH patients that deserve to be treated, according to the consensual definition agreed between experts and regulatory agencies.
Advertisement